A maternal-emergency pharmacology curriculum focused on eclampsia, acute severe pregnancy/postpartum hypertension and postpartum hemorrhage. It emphasizes rapid protocolized treatment while preserving the critical-care habit of reassessing airway, shock and competing diagnoses.
Use magnesium sulfate as first-line seizure prevention/treatment for preeclampsia/eclampsia and recognize toxicity early.
Treat persistent severe pregnancy/postpartum BP promptly with labetalol, hydralazine or immediate-release oral nifedipine according to the patient phenotype.
Use oxytocin as first-line uterotonic for atony while activating the full PPH bundle.
Give tranexamic acid early for established PPH when indicated rather than as delayed rescue after massive blood loss.
Avoid uterotonic and antihypertensive choices that conflict with asthma, bradycardia, cardiomyopathy or severe pulmonary edema.
The table below is a selection framework. Open the individual monograph for exact dosing, preparation, renal/CRRT/IHD adjustment, interactions and evidence traceability.
ICU role: Drug of choice for eclampsia seizure treatment/prevention.
Monitor: Reflexes, respiratory rate, urine output/renal function and clinical seizure control.
ICU role: First-line IV severe-hypertension option in pregnancy/postpartum.
Monitor: BP/HR, bronchospasm and perfusion.
ICU role: First-line IV arteriolar vasodilator for acute severe pregnancy/postpartum hypertension.
Monitor: Frequent BP, HR/symptoms and fetal monitoring if antepartum.
ICU role: First-line oral severe-BP rescue option in pregnancy/postpartum, particularly without immediate IV access.
Monitor: BP every protocol-defined interval, HR/symptoms.
ICU role: First-line uterotonic for uterine-atony PPH.
Monitor: Uterine tone, quantified blood loss, hemodynamics, sodium with prolonged exposure.
ICU role: Antifibrinolytic for postpartum hemorrhage and selected major bleeding.
Monitor: Bleeding trajectory, thrombosis risk and renal function.
ICU role: Membrane-stabilizing calcium and antidotal support for clinically important magnesium toxicity.
Monitor: ECG, neuromuscular/respiratory recovery, ionized calcium.
| Agent | ICU role | Why I choose it | Why I hesitate | What I monitor |
|---|---|---|---|---|
| Magnesium Sulfate Electrolyte / Multi-Mechanism Membrane & Neuromuscular Modulator | Drug of choice for eclampsia seizure treatment/prevention. | ✓ Use in severe preeclampsia/eclampsia under obstetric protocol; repeat/infuse according to seizure and renal status. | ✕ Accumulates in renal failure; loss of reflexes, respiratory depression and heart block are toxicity clues. | Reflexes, respiratory rate, urine output/renal function and clinical seizure control. |
| Labetalol Combined Alpha-1 and Non-Selective Beta Blocker | First-line IV severe-hypertension option in pregnancy/postpartum. | ✓ Good when rapid BP and HR reduction are both acceptable. | ✕ Avoid/limit in asthma, bradycardia, heart block and decompensated cardiac failure. | BP/HR, bronchospasm and perfusion. |
| Hydralazine IV Direct Arteriolar Vasodilator | First-line IV arteriolar vasodilator for acute severe pregnancy/postpartum hypertension. | ✓ Useful when beta blockade is undesirable. | ✕ Response may be delayed/variable; excessive hypotension/headache and fetal heart-rate changes can occur. | Frequent BP, HR/symptoms and fetal monitoring if antepartum. |
| Nifedipine Immediate-Release (Obstetric Rescue) Dihydropyridine Calcium-Channel Blocker | First-line oral severe-BP rescue option in pregnancy/postpartum, particularly without immediate IV access. | ✓ Avoids beta blockade and can be deployed quickly in a structured obstetric protocol. | ✕ Do not extrapolate immediate-release nifedipine to routine non-obstetric hypertensive emergencies. | BP every protocol-defined interval, HR/symptoms. |
| Oxytocin Uterotonic / Oxytocin-Receptor Agonist | First-line uterotonic for uterine-atony PPH. | ✓ Start promptly while uterine massage and the PPH bundle proceed. | ✕ Does not fix retained tissue, trauma or coagulopathy; prolonged/high exposure can cause hyponatremia. | Uterine tone, quantified blood loss, hemodynamics, sodium with prolonged exposure. |
| Tranexamic Acid Antifibrinolytic / Synthetic Lysine Analog | Antifibrinolytic for postpartum hemorrhage and selected major bleeding. | ✓ Give early after PPH diagnosis when no contraindication; benefit falls with delay. | ✕ Does not replace uterotonics/source control and is not a treatment for every pregnancy-associated bleed. | Bleeding trajectory, thrombosis risk and renal function. |
| Calcium Gluconate Electrolyte / Cardiac Membrane Stabilizer | Membrane-stabilizing calcium and antidotal support for clinically important magnesium toxicity. | ✓ Use for significant magnesium-associated respiratory/cardiac toxicity while stopping Mg and supporting ventilation. | ✕ Do not give just for an asymptomatic therapeutic Mg concentration. | ECG, neuromuscular/respiratory recovery, ionized calcium. |
Why: Magnesium is first-line for eclampsia, but refractory seizures require escalation and alternative-diagnosis evaluation.
Why: All three can be first-line; comorbid asthma/bradycardia changes the safest choice.
Why: PPH management is concurrent and cause-directed.
Why: Renal clearance falls and magnesium can progress to respiratory/cardiac toxicity.
Recognition becomes selection, then organ-failure adjustment, competing physiology and senior-level prioritization.
Pregnant patient with severe hypertension has a generalized tonic-clonic seizure.
Protect airway/oxygenation and give magnesium sulfate as first-line eclampsia therapy while treating severe BP and arranging definitive obstetric management.
Postpartum BP 174/116, HR 58, asthma history.
Treat promptly with an accepted first-line non-beta-blocking option such as IV hydralazine or immediate-release oral nifedipine, while evaluating postpartum preeclampsia.
On Mg infusion, urine output falls, reflexes disappear and RR is 8/min.
Stop magnesium, support ventilation and give calcium for clinically significant toxicity while checking Mg/renal function; do not continue prophylaxis through toxicity.
Atonic PPH is ongoing in a patient with severe asthma.
Use oxytocin/TXA and cause-directed PPH escalation; avoid a uterotonic choice that significantly worsens bronchospasm risk and coordinate obstetric/anesthesia management.
Postpartum severe hypertension, hypoxemia, diffuse B-lines, reduced LV function and ongoing magnesium infusion.
Treat as a combined maternal cardiopulmonary emergency: control severe BP with an appropriate titratable agent, use respiratory/diuretic support as indicated, review magnesium/renal status and avoid reflex fluids. Continue seizure prophylaxis only if safe and coordinate obstetric/cardiology/critical care.
Spans four genuinely distinct ICU indications — torsades de pointes, adjunctive severe asthma therapy, eclampsia/severe preeclampsia, and simple hypomagnesemia repletion — each with its own mechanism-relevant dosing; no single do…
Combined alpha-1 and beta-1/beta-2 blocker (1:7 alpha:beta ratio IV) for hypertensive emergencies, stroke, and aortic dissection — lowers BP and HR simultaneously.
Direct arteriolar vasodilator used as a first-line option for acute-onset severe hypertension in pregnancy/postpartum, usually in small repeated IV doses under an obstetric emergency protocol; response can be less predictable tha…
Immediate-release oral nifedipine is an accepted first-line option for acute-onset severe hypertension in pregnancy/postpartum, especially when IV access is unavailable; this specific use should not be generalized to routine subl…
First-line uterotonic for prevention/treatment of uterine-atony postpartum hemorrhage, combined with rapid cause-directed PPH care rather than used as a substitute for hemorrhage control, tranexamic acid, transfusion or operative…
Synthetic lysine analog that competitively blocks plasminogen lysine-binding sites, inhibiting plasmin formation and fibrin clot degradation, reducing mortality in bleeding trauma (CRASH-2) and postpartum hemorrhage (WOMAN) when …
First-line cardiac membrane stabilizer for hyperkalemic ECG changes and definitive replacement therapy for symptomatic hypocalcemia — the single most important teaching point is that it stabilizes the myocardium without changing …
This Masterclass teaches selection and reasoning. Exact dosing, concentration, infusion preparation, renal/hepatic/RRT adjustment and monitoring must be checked in the linked medication monograph and the institution's current formulary/protocol. Local resistance patterns and regulatory drug availability can change faster than a static teaching page.